Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Role of Omega-6 Fatty Acids in Hepatocellular Carcinoma Development.
A clinical trial registry entry from Sohag University investigating the role of omega-6 fatty acids in the development of hepatocellular car…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Cabozantinib to Treat Recurrent Liver Cancer Post Transplant [Phase 2]
This clinical trial update notes a Phase 2 study of cabozantinib for recurrent hepatocellular carcinoma in liver transplant patients, and it…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors [Phase 1]
Phase 1 study of TBI-1301, an NY-ESO-1–specific TCR gene-transduced autologous T cell therapy, in solid tumors; the trial is currently activ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of GV20-0251 in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
GV20 Therapeutics is evaluating GV20-0251 in a Phase 1/2 trial for adults with various solid tumors, and the study is currently recruiting. …
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC [Phase 3]
A Phase 3 trial update comparing infusional FOLFOX plus Camrelizumab and Apatinib versus HAIC-FOLFOX plus Camrelizumab and Apatinib for adva…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors [Phase 1]
Phase 1 clinical trial update for HRYZ-T102 TCR-T cell therapy targeting AFP-positive advanced hepatocellular carcinoma and other solid tumo…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation [NA]
This clinical trial update notes recruitment for an adjuvant PD-1 inhibitor in patients with early-stage hepatocellular carcinoma after micr…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Precision Medicine for Liver Tumours With Quantitative Magnetic Resonance Imaging and Whole Genome Sequencing
Clinical trial evaluating precision medicine for liver tumours using quantitative MRI and whole-genome sequencing, sponsored by Perspectum; …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC [Phase 2]
This is a Phase 2 clinical trial evaluating immune checkpoint inhibitors with or without anti-VEGF antibody or tyrosine kinase inhibitors fo…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma [NA]
This clinical trial protocol compares tenofovir alafenamide (TAF) monotherapy to entecavir (ETV) plus TAF for hepatitis B-related hepatocell…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
This clinical trial update describes a noninvasive miRNA-based test being explored for screening gastrointestinal cancers. It is currently r…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: National Liver Cancer Screening Trial [Phase 4]
Phase 4 liver cancer screening trial is currently recruiting, sponsored by the University of Texas Southwestern Medical Center.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE) [NA]
A single-arm Phase II clinical trial evaluating carbon ion radiotherapy for hepatocellular carcinoma in patients previously treated with tra…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Neo-Adjuvant TACE and Atezolizumab Plus Bevacizumab Therapy for High-Risk Recurrent Hepatocellular Carcinamo [Phase 2]
This Phase 2 trial is evaluating the safety and effectiveness of neoadjuvant TACE combined with atezolizumab and bevacizumab in patients wit…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Clinical Trial of TB511 in Advanced Solid Tumors [Phase 1, Phase 2]
This update covers an early-phase trial of TB511 in advanced solid tumors, including non-small cell lung cancer and prostate cancer, with co…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy with Lipiodol embolization for advanced hepatocellular carcinoma …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
A Phase II single-arm study evaluating carbon ion radiotherapy combined with atezolizumab and bevacizumab for advanced hepatocellular carcin…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma [NA]
A clinical trial is evaluating whether different infusion times of tislelizumab improve outcomes for patients with postoperative high-risk h…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A Study of GV20-0251 in Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 clinical trial update indicates that GV20-0251 is being studied in advanced or refractory solid tumors and is currently recruit…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D) [NA]
Clinical trial RAPY90D investigates personalized Yttrium-90 dosimetry-based radioembolization with curative intent for unresectable hepatoce…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Imjudo & Imfinzi PMS
AstraZeneca-sponsored trial update notes ongoing recruitment for Imjudo (tremelimumab) plus Imfinzi (durvalumab) in hepatocellular carcinoma…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Erlotinib for Hepatocellular Carcinoma Chemoprevention [Phase 2]
Phase 2 clinical trial evaluating erlotinib for chemoprevention of hepatocellular carcinoma in patients with cirrhosis or advanced liver fib…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Evaluation of Risk of hEpatocellular Carcinoma [NA]
This clinical trial update describes an ongoing study evaluating the risk of hepatocellular carcinoma in patients with non-alcoholic steatoh…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment [Phase 2]
A Phase 2 clinical trial update evaluating the combination of dalpiciclib and camrelizumab in hepatocellular carcinoma patients who have pre…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Next Generation " Pre-clinical Model for Colorectal Cancer Metastases and Hepatocellular Carcinomas
This clinical trial update reports the completion of a pre-clinical model study focused on colorectal cancer metastases and hepatocellular c…